Clinical Trial Update: To Study GSP 301 in Patients With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 study of GSP 301 in seasonal allergic rhinitis completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• GSP 301

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-28